Why Do We Have a Metallic Taste in the Mouth? Causes and Treatment
In this article
A metallic taste in the mouth: first ask the right question
The worst answer you can give someone who constantly tastes coins, rust or blood is a long list of "possible causes". The causes behind this complaint form a short, rankable and largely well-established list—and at the top is something most articles place last: the medications being taken. This article explains what taste disorders actually are, why a metallic taste differs from other taste complaints, and what works and what does not in people receiving cancer treatment, without concealing its sources.
- For most people who say "I have lost my taste", the problem is smell rather than taste. Among people with taste complaints alone, taste testing is abnormal in 25.4%, while smell testing is abnormal in 44.4%.
- Taste impairment is much more common than people think and is largely silent. Among adults over 40 in the United States, measured taste impairment is 17.3%, while the self-reported rate in the same people is 5.3%.
- A metallic taste is different from "loss of taste". It is usually a phantom taste felt when there is nothing in the mouth, and its causes form a much shorter list: medications, dry mouth, oral diseases and cancer treatment.
- Medications are by far the leading cause. Taste impairment is listed as an adverse effect in 17% of 1,645 medication records in a national drug information database.
- Taste change in cancer treatment is the rule, not the exception —approximately 70% in chemotherapy and ~79% by patient report in head-and-neck radiotherapy. Yet there is no proven treatment; zinc and glutamine trials in this group have been negative.
- The most striking finding from Turkey: Among lung cancer patients receiving chemotherapy, 68.6% had received no information about this adverse effect.
First, the terms: which disorder are we discussing?
Taste complaints are not a single condition. Without knowing which one is involved, neither causes nor treatment can be discussed. The distinctions below make the rest of this article understandable.
| Term | What does it mean? | In everyday language |
|---|---|---|
| Ageusia | The sense of taste is completely lost | "I cannot taste anything." True ageusia is very rare —it is almost never found in people who say this. |
| Hypogeusia | Taste perception is reduced | "Flavors seem faint; I add more salt." This is the most common form of true taste impairment. |
| Dysgeusia | Taste is altered or distorted | An umbrella term: coffee tasting metallic and an unexplained bitter taste in the mouth both fall under it. |
| Phantogeusia (phantom taste) | A taste perceived when there is nothing in the mouth | The main subject of this article. This is exactly what is meant by "I taste coins in my mouth even when I am not eating anything". |
| Parageusia | Perceiving the taste of an actual food differently | "Meat tastes like soap." Sources use this term inconsistently; it overlaps with dysgeusia. |
| Cacogeusia | A persistent disgusting, unpleasant taste | This is the condition described in pine nut syndrome (below). |
| Aliageusia | Foods that used to be pleasant now seem repulsive. | The experience most often described by chemotherapy patients; it is usually behind the statement "I cannot eat meat". |
Dry mouth (xerostomia) and reduced saliva (hyposalivation) are not the same thing. Xerostomia is the mouth feeling dry—measurements may be normal. Hyposalivation is a measured reduction: it is diagnosed when stimulated salivary flow is below 0.5-0.7 mL per minute and unstimulated flow below 0.1 mL (normal values: stimulated 1.5-2.0 mL/min, unstimulated 0.3-0.4 mL/min). This distinction is critical for taste because taste substances must dissolve in saliva to reach the receptor.
"I have a bad taste in my mouth" and "my taste system is impaired" are not the same thing either. In reflux, acid coming from the stomach into the mouth really creates a sour-bitter taste—but this does not mean the taste system is impaired. In the first case, a substance is present in the mouth; in the second, perception is altered. The investigation of causes differs between the two.
The biggest misunderstanding: most of what we call "taste" is actually smell
The sense of taste consists of five qualities: sweet, sour, salty, bitter and umami (the savory flavor in foods such as broth, cheese and tomatoes). Beyond this, the tongue does nothing else.
In contrast, flavor is much broader: taste + retronasal smell (odor molecules rising from the mouth through the back of the nose while chewing and swallowing) + chemical sensation (the heat of pepper, the cooling of mint, the tingling of soda) + texture and temperature. Strawberries, coffee, lamb—none of these are "tastes"; they are flavors, and a large part is smell.
One source states this more sharply: an estimated 95% of taste disorders actually result from smell impairment. Because we could not verify the original study behind this rate, we only report it here; the 25.4% / 44.4% figures above are the more reliable ones.
How common is it? The gap between what is measured and what is felt
The frequency of taste impairment can vary up to threefold depending on which question you ask. In the United States, the same national health survey examined it through both testing and questioning, with these results:
The statement "More than 200 thousand people in the United States see a doctor each year for taste and smell problems" really does come from NIDCD, part of the US National Institutes of Health—but it is unsourced and can be traced back to a 2009 fact sheet; the underlying data are not specified. We therefore did not use it as a headline figure in this article. The survey data above are both more current and more informative.
Why is a metallic taste a separate topic?
General "taste loss" and a metallic taste are different problems. Taste loss usually originates in smell and develops insidiously. A metallic taste, however, is typically a phantom taste: even when not eating anything, the person tastes coins, rust, blood or a "battery terminal" in the mouth. This distinction is useful because the causes of a metallic taste form a much shorter and much better-documented list.
- Medications —by far the most common and best-documented cause
- Cancer treatment —chemotherapy, head-and-neck radiotherapy, some targeted drugs
- Dry mouth —itself often caused by medications
- Oral diseases —gum disease, oral fungal infection (thrush), poor oral care
- Zinc deficiency —and, indirectly, liver and kidney diseases that lead to it
- After infection —COVID-19 and other upper respiratory tract infections
- Pregnancy
- Nervous system causes —stroke, head trauma, ear/tonsil surgery, epilepsy
- Cases with no identified cause —approximately one-third even at specialist centers
1. Medications: the undisputed leader on the list
In the Netherlands' national drug information database, 1,645 medication records were screened, and dysgeusia was listed in 282 (17%), while hypogeusia was listed as an adverse effect in 61 (3.7%).
This is not a clinical trial; it is a review of medication information leaflets. The correct statement is: "Taste impairment is listed as a possible adverse effect in the leaflets of 17% of the medication records reviewed." This does not mean "17% of medications cause taste impairment" or "it occurs in 17% of patients". Being listed in a leaflet does not establish frequency or causality.
In the same study, the drug classes most often listing taste impairment were:
Medications that should be mentioned by name
| Medication | Level of evidence and frequency | What you need to know |
|---|---|---|
| Metformin (diabetes) |
~3% —stated in the leaflet approved by the US drug authority: "About 3 in every 100 people taking metformin have an unpleasant metallic taste when starting the medication." | It usually occurs at the beginning and is temporary. Because it is very widely used in Turkey, it is the first medication to ask about when someone reports a metallic taste. |
| Terbinafine (nail/skin fungal infection) |
2.8% (0.7% with placebo)—in the special warning section of the approved leaflet | The most important medication warning in this article. The leaflet says exactly this: taste impairment "may be severe, prolonged or permanent" —it explicitly states that it can last longer than a year and can be permanent. It also "may be severe enough to result in decreased food intake, weight loss, anxiety and depressive symptoms." If your taste changes after starting terbinafine, tell your physician without delay. |
| Metronidazole / tinidazole (some bacterial and parasitic infections) |
In a meta-analysis, the rate for metronidazole was 15.5%, and for tinidazole 20.6% — but the editorial standards of the journal publishing the study are disputed; treat the figures as indicative | A metallic taste is a classic, well-known characteristic of these drugs; it resolves when treatment ends. |
| Tyrosine kinase inhibitors (cabozantinib, sunitinib, pazopanib, nintedanib) |
Analysis of the US adverse-event reporting database showed a strong signal; cabozantinib had the strongest signal. Of all taste-smell events reported in this group, more than 90% were taste disorders. | This is a reporting signal, not a frequency rate —it does not answer "how many patients experience it". A mechanism identified in 2026 is interesting: by inhibiting the KIT pathway, these drugs disrupt taste bud cell renewal. |
| Captopril, penicillamine (blood pressure; rheumatological diseases) |
They appear on all the classic lists; no reliable frequency figure was found | Their sulfur-containing (sulfhydryl) structures are thought to bind zinc—this is a textbook-level mechanism, not a proven one. |
| Clarithromycin, lithium, disulfiram, gold salts, acetazolamide, zopiclone, levodopa, iron supplements | They appear on standard lists; there is no verified frequency figure for any of them | Percentages were deliberately omitted from this article. A small irony: while zinc deficiency causes taste loss, zinc supplements themselves are sometimes also listed as a cause of taste impairment. |
For a new metallic taste, the first thing to do is write down all medications started in the past three months and take the list to the physician. Medications are both the most common cause and the easiest to address: once the responsible drug is identified, the solution is often free and rapid. Do not stop your medication on your own —particularly antibiotics, blood pressure drugs and diabetes drugs.
2. Dry mouth and oral causes
Taste substances must dissolve in saliva to reach the receptors. Dry mouth is therefore both a cause and an amplifier of taste impairment: in chemotherapy patients, dry mouth increases the risk of taste change by more than twofold (OR 2.04).
Gum disease is a little-known but treatable cause. In a study of 183 people, self-reported taste perception in patients with periodontitis was markedly lower than in healthy participants; four weeks after nonsurgical gum treatment, taste perception improved significantly in all groups (p<0.05). Although this is not definitive evidence because the study used subjective measurements, it is the most concrete data behind the advice to "see the dentist first".
Oral fungal infection (oral candidiasis, thrush) is also a recognized cause and is extremely easy to treat—it should be investigated particularly in denture users, people using steroid asthma inhalers and those receiving cancer treatment. Current publications exist, but we could not access their numerical data, so we give no percentage.
Between fillings, crowns or implants made of different metals, small, measurable electrical currents can occur —that physics is correct. A metallic or "electrical" sensation lasting a few days immediately after a new filling is also real and usually resolves on its own.
However, the claim that "oral galvanism" causes chronic systemic diseases is not an evidence-based diagnosis. This was a public debate in Sweden for years. The title of one clinical assessment summarized the result as follows: no evidence of toxic mercury exposure, but anxiety disorder is an important background factor. Today, almost everything found when searching the internet on this subject is not clinical literature but advertising for "metal-free dentistry". Be cautious about approaches recommending wholesale replacement of all metal dental work because of a metallic taste.
3. After infection: COVID-19 and others
COVID-19 brought taste disorders back into medical focus. In a meta-analysis of 235 studies involving 138,015 patients, the prevalence of taste loss in acute COVID-19 was 36.62% (95% CI 33.02-40.39). A notable point is that the rate in studies using direct tests was 45%, compared with 36.11% in studies based on self-report, and the difference was not significant—in other words, objective measurement did not contradict what patients said; it confirmed it.
For the 2022 first version of this meta-analysis, an expression of concern was published; the version was withdrawn and republished in 2023. The figures above are from the 2023 version. When reading a source on COVID and taste loss, it is worth checking which version is cited.
The recovery news is good. In a meta-analysis of 3,699 patients, taste returned to normal in 78.8% by 30 days, 87.7% by 60 days and 90.3% by 90 days; the estimated rate of persistent taste impairment was 4.4%(95% CI 1.2-14.6). The median time to taste recovery was 12.4 days. Female sex was associated with slower recovery.
A study of 28 long COVID patients reporting altered taste showed in tongue biopsies that the taste buds remained structurally intact, while expression of the molecules transmitting taste signals was reduced, particularly sweet, umami and bitter perception in the PLCβ2 pathway. The loss was least pronounced for sour taste.
The implication for the reader is important: the taste buds have not disappeared; signal transmission is impaired. Structurally destroyed tissue is not expected to return, whereas a signaling problem may be reversible. This is a real reason for hope for people with persistent taste complaints in long COVID.
The situation differs in upper respiratory tract infections other than COVID: classically, these infections cause loss of smell; taste-specific evidence is weak, and we give no frequency figure in this article.
4. Zinc deficiency: the most overlooked cause
Zinc is a building block of an enzyme in saliva called carbonic anhydrase VI (gustin); this enzyme is thought to play a role in maintaining taste buds. This mechanism is a leading hypothesis in the field, not an established fact —although classic sources exist, we could not access their full texts.
The answer to whether zinc supplementation works has two parts, and this distinction is almost never made in patient information texts:
| In which situation? | Evidence | Result |
|---|---|---|
| Zinc deficiency, unexplained (idiopathic) taste impairment, taste impairment related to chronic kidney failure | 12 randomized trials, 938 participants (2023 meta-analysis) | It works. Effective doses are 17-86.7 mg of elemental zinc daily for 3-6 months; benefit is concentrated at the upper end of the dose range (68-86.7 mg/day). |
| Taste change caused by cancer treatment | Phase III, double-blind, placebo-controlled trial (169 evaluable patients) | It does not work. In the first 2 months, taste impairment occurred in 73% in the zinc arm and 84% with placebo (p=0.16). The study's own conclusion: "Zinc sulfate, as given in this study, did not prevent taste alterations in patients receiving radiotherapy to the oral-pharyngeal region." |
Doses found effective for taste impairment (68-86.7 mg of elemental zinc daily) are far above daily requirements. Prolonged high-dose zinc leads to copper deficiency, resulting in anemia and neurological damage. Zinc should therefore be a treatment tried after checking blood levels and under a physician's supervision, not a solution picked up from a supermarket shelf.
A detail specific to Turkey: According to TİTCK's letter dated 20.12.2019, solid-form products containing 25 mg or more of elemental zinc are considered prescription medicines (the same applies to 35 mg/day and above in adults). Thus, doses found effective for taste impairment in Turkey already require a physician's decision. In the same regulation, approved indications are zinc deficiency, Wilson disease, acrodermatitis enteropathica and diarrhea in children older than 6 months— taste impairment is not on this list. This document dates from 2019; confirm the current situation with TİTCK.
5. Systemic diseases: what is true and what is not
| Condition | What do we really know? |
|---|---|
| Liver diseases | This is where a common belief needs correcting. Liver disease genuinely impairs taste: the rate rises from 5% in those without fibrosis to 33% in advanced stages and 59% in decompensated chronic liver disease. However, this impairment is reduced taste acuity, not a metallic taste, and its main cause is zinc deficiency. The metallic taste seen in liver patients is largely attributed in the literature to the medications they take. In short, the statement "if you taste rust in your mouth, check the liver" is not correct as it stands. |
| Kidney failure / dialysis | Taste impairment is a known problem; the strongest indirect evidence is that zinc supplementation works in this group. Proposed mechanisms include uremic substances accumulating in saliva and zinc deficiency. The prevalence figure in dialysis patients could not be verified —we give no percentage in this article. |
| Pregnancy | In a longitudinal study, 26% of pregnant women reported a change in taste sensitivity; the pattern described was increased bitter perception and reduced salt perception. A separate rate specific to metallic taste and a trimester distribution could not be obtained from this study. Although it is commonly attributed to estrogen and hCG, no primary evidence for this mechanism was found; the chemosensory literature in pregnancy focuses mainly on smell. |
| Diabetes | There is genuine literature reporting altered taste perception, but there is no verified frequency figure. There is also an important confounder: a large proportion of these patients take metformin. |
| Reflux | Stomach contents entering the mouth directly create a sour-bitter taste—that is real. However, there is no solid evidence that reflux impairs the taste system. This is a perfect example of the distinction at the start of the article between "a bad taste in the mouth" and "an impaired taste system". |
| Sinusitis / chronic rhinosinusitis | A systematic review states that taste complaints in these patients have historically been attributed to smell loss, but that there is evidence of true taste impairment independent of smell. We could not access pooled prevalence figures. |
| Allergic rhinitis (hay fever) | No taste-specific evidence was found. If there is an effect, it is most likely through smell. Older texts listing hay fever as a cause of metallic taste reflect a failure to make this distinction. |
| Ketogenic diet / ketosis | The claim of an "acetone-related metallic taste" is widespread online, but we found no support for it in the literature we could access. We mark it as an unverified popular belief. |
| Heavy metal poisoning | ⚠ Contrary to expectations, metallic taste is not a standard symptom in the clinical presentations of lead and mercury poisoning. The idea "metallic taste = heavy metal poisoning" has a much weaker foundation than popular health articles suggest. Read this as a warning against "heavy metal detox" services using metallic taste as a marketing hook. The only verified exception is metal fume fever below. |
Two useful examples: pine nut syndrome and metal fume fever
In a controlled trial, six healthy volunteers ate 6-8 pine nuts from a suspect batch, and all six developed taste impairment; four described the "classic bitter and metallic taste" that appeared 1-2 days after eating. Symptoms lasted 2-5 days in those most affected, and did not recur during one year of follow-up. Fatty acid analysis identified the responsible species as Pinus armandii.
Why it matters: a delayed-onset, self-limiting, entirely harmless and well-documented cause of metallic taste. A useful reminder for an anxious reader.
It occurs after inhaling zinc oxide fumes produced during galvanized-steel welding. The presentation is: a "sweetish metallic taste" with fever, chills, nausea, muscle and joint pain, weakness and a dry cough. It begins 2-10 hours after exposure and resolves within 24-48 hours. There is a classic "Monday morning" pattern: tolerance develops during the working week and disappears over the weekend.
Particularly relevant to Turkey: given the size of the welding, metalworking and shipbuilding workforce, this diagnosis may be missed unless occupation is asked about.
An oral burning sensation without a visible cause, lasting more than 2 hours a day for longer than 3 months. Its population prevalence is 0.1-3.7%; it is approximately 7 times more common in women than men and peaks after age 60. Approximately 70% of patients have altered taste, often described as "metallic and bitter". 46-67% report dry mouth—even though measured salivary flow is normal in most.
Why it matters: it is one of the most often overlooked causes of a persistent metallic taste.
Nervous system causes
Taste information from the front two-thirds of the tongue is carried by a fine nerve called the chorda tympani, which passes through the middle ear. This anatomy explains taste impairment following ear surgery, tonsil surgery and some dental procedures. Although there is extensive literature, we could not verify frequency figures; we therefore explain the anatomy without giving percentages.
Other neurological causes include stroke (documented in a prospective study of 102 patients, but the frequency figure was inaccessible), head trauma (24% of taste disorders in a specialist-center series), multiple sclerosis (in 73 patients and 73 matched controls, salt perception was below the fifth percentile in 31.5%, sweet in 24.7%, sour in 21.9% and bitter in 15.1%), and epilepsy (gustatory aura).
Cases with no identified cause are also far from uncommon. In a series of 491 patients with taste disorders assessed at a specialist taste-smell center, the distribution was: idiopathic (unknown cause) 34%, post-traumatic 24% and postoperative 15%. Thus, even at specialist centers, no cause can be identified in approximately one in three patients. This is important for setting expectations appropriately.
A metallic taste alone is almost never an emergency. What determines urgency is not the taste itself, but what accompanies it and its timing.
- If it began within minutes —after a medication, injection, intravenous infusion, bee sting or food, particularly with itching, redness, hives, lip or tongue swelling, wheezing, throat tightness, dizziness or a sense that "something bad is going to happen": it may be an allergic reaction; go to the emergency department. In the World Allergy Organization's grading system, metallic taste is among mild systemic allergic symptoms; what matters is not the taste itself but when it appears and what accompanies it.
- If there is a new neurological sign —facial drooping, arm weakness, speech disturbance, one-sided numbness, vision loss or severe imbalance: an emergency. In contrast, on its own, a new metallic taste is essentially never a stroke.
- A recurrent metallic or unpleasant taste lasting seconds and exactly the same each time —particularly with a rising sensation from the stomach, a feeling of "having experienced this before", a lapse in awareness or automatic movements such as lip-smacking—may be a focal seizure and requires neurological assessment. The distinguishing feature is duration: a drug- or treatment-related metallic taste lasts hours to weeks; a gustatory aura lasts seconds and is always the same.
- If there is an oral sore that has not healed for three weeks, a white or red patch, or a mass: this finding requires urgent assessment independently of the taste complaint. Note: taste change is not a recognized initial symptom of oral cancer—the warning sign is the nonhealing lesion, not the change in taste.
- Unexplained weight loss is an important warning sign on its own and should be assessed without delay. There is no evidence that the combination "metallic taste + weight loss" is a cancer-specific sign —but the weight loss itself must be investigated in any case.
- If your taste changed after starting terbinafine (an antifungal medication): do not wait; tell your physician immediately. The leaflet explicitly states that this adverse effect may be prolonged or permanent; recognizing it early means stopping the medication early.
- If you are a welder or metalworker and develop fever, chills and a cough together with a metallic/sweetish taste 2-10 hours after work, metal fume fever should be considered and the occupational physician consulted.
Cancer treatment and taste change
In patients receiving cancer treatment, taste change is the rule, not the exception. Yet it is one of the adverse effects least often explained to patients—and, the most honest part of this section, there is no proven treatment.
The frequently repeated statement in Turkish and English sources that "86% of patients receiving chemotherapy and/or radiotherapy experience taste change" could not be traced to a verified source. The closest source we could trace reports advanced cancer patients having abnormalities of taste or smell —both the patient group and what was measured differ. It was therefore not used in this article; the verified figures above were used instead.
How much with which drug?
In a study of one hundred patients, individual taxane drugs showed the following pattern:
| Drug | Taste change | Severity | How long does it last between cycles? |
|---|---|---|---|
| Docetaxel | 95% (18/19) | ~70% moderate-to-severe | In ~50%, longer than 8 days |
| Nab-paclitaxel | 52% (11/21) | ~90% mild-to-moderate | In ~40%, 1-3 days |
| Paclitaxel | 50% (30/60) | ~90% mild-to-moderate | In ~40%, 1-3 days |
| Entire group | 59% (59/100) |
Patient numbers are small—only 19 in the docetaxel arm—so 95% is a finding from a single study, not an established docetaxel rate. Nevertheless, there is a clinically meaningful distinction: with docetaxel, taste change is both more severe and lasts much longer between cycles. Verified drug-specific frequency figures for platinum derivatives, cyclophosphamide, methotrexate and 5-FU could not be found, so none are given in this article.
Targeted drugs (tyrosine kinase inhibitors) have a strong reporting signal, highest for cabozantinib, followed by sunitinib and pazopanib; the mechanism identified in 2026 is that these drugs disrupt taste bud cell renewal through the KIT pathway.
In a study published in 2026 with a particularly strong design, 49 patients who had completed immune checkpoint inhibitor treatment (a median of 3.7 years since the last cycle) were compared with 49 relatives of patients. Objective testing found hypogeusia in 31% of patients and 29% of relatives — no significant difference. There was no difference in smell or salivary flow either.
The second finding of this study is at least as instructive as the first: approximately 30% of healthy relatives also had measurable taste impairment. This is the clearest evidence of the opening theme that "measured impairment is common and silent"—and shows why studies without a comparison group can mislead.
The dose relationship in radiotherapy: more complex than textbooks suggest
In head-and-neck radiotherapy, taste starts to deteriorate from the second week of treatment and worsens with cumulative dose. In a prospective study, taste thresholds began improving at weeks 14-18 and returned to pretreatment levels at approximately 4.5 months.
However, which structure's dose is decisive is genuinely disputed, and this debate directly affects the explanation given to patients. In a prospective study of patients with oropharyngeal cancer:
- No association was found between the mean dose to taste-bud-bearing tongue mucosa (47.4 Gy) and taste impairment (OR 1.003; p=0.90).
- In contrast, in the subgroup not receiving chemotherapy, salivary gland dose was decisive: each 1 Gy increase in mean dose to the ipsilateral parotid gland increased risk (OR 1.071; p=0.036); the dose was 41.3 Gy in those with taste impairment and 35.9 Gy in those without.
- In the long term, 38 patients (33%) still had moderate-to-severe taste impairment a median of 58 months after radiotherapy.
Thus, the two explanations patients hear—"your taste buds were damaged" and "it is because of your dry mouth"—are actually competing hypotheses. The honest answer is "probably both, and we are still trying to determine which plays the greater role". Work continues to define taste-bud-bearing tongue mucosa as a separate "organ at risk" and set dose limits for it.
The source we could access gave internally inconsistent results for widely circulated thresholds such as "taste becomes impaired above this many Gy". Therefore, this article deliberately gives no numerical Gy threshold.
When does it improve?
| Chemotherapy | Head-and-neck radiotherapy | |
|---|---|---|
| Onset | Usually in the first cycles; receiving two or more cycles increases risk approximately 4-fold (OR 3.95) | Measurable from week 2 of treatment |
| Course | Increases as cycles progress; duration between cycles varies by drug (paclitaxel 1-3 days, docetaxel longer than 8 days) | Worsens with cumulative dose |
| Recovery | In most patients, it returns to normal a few months after treatment ends | Thresholds improve at weeks 14-18; in one study, ~4.5 months to pretreatment levels |
| Persistent impairment | No verified long-term rate was found | ~25% have long-term impairment; in one cohort, 33% still had moderate-to-severe impairment at a median of 58 months |
There is an apparent contradiction here: some sources say taste change after radiotherapy is "permanent in many patients", while the prospective study found recovery at 4.5 months. Both are true and can be reconciled as follows: most patients improve substantially within months; a minority between one-quarter and one-third do not.
Consequences: why should it matter?
- Quality of life. In a Turkish study of 330 patients, the association between taste change and quality of life was significant (r=−0.329; p<0.001), explaining 10.5% of the variance.
- Nutritional risk—but read carefully. In the same study, 21.8% of patients were at moderate risk of malnutrition; the association with taste change was statistically significant, but explained only 1.4% of the variance. In other words, taste change alone is not the main driver of nutritional impairment.
- Not every study finds weight loss. In a breast cancer chemotherapy cohort, despite marked impairment in all taste qualities and measurable impairment in 32.9% on testing, body weight and energy intake had not changed; patients had adapted by reducing sugar and alcohol and increasing protein and fiber.
- Symptoms cluster. In chemotherapy, dry mouth doubles the risk (OR 2.04), and oral sores (mucositis) increase risk almost fourfold (OR 3.72). This means that treating mucositis is also a taste intervention.
- It matters beyond nutrition too. A current review reports that loss of taste and smell is associated with cognitive decline and a poorer treatment prognosis.
One piece of data we could not find: there is no study quantifying interruption of cancer treatment because of taste change. This claim is made frequently; evidence is lacking.
What works? The honest answer: very little
| Intervention | Evidence | Result |
|---|---|---|
| Zinc | Phase III, double-blind, placebo-controlled, 169 patients | Negative (73% vs 84%; p=0.16). A radiotherapy-specific meta-analysis says "effective for prevention, little effect in ongoing impairment"; the result for taste recovery is nonsignificant. |
| Oral glutamine | Randomized, double-blind, placebo-controlled (30 g daily during taxane treatment) | Negative. The study's own words: "Oral glutamine at the dose used did not reduce the incidence of subjective taste disturbances or changes in taste perception due to taxane chemotherapy compared with placebo." ⚠ A 2025 review presenting this study as positive is a good example of why secondary sources need checking. |
| Nutritional counseling + taste/smell training | Single-center phase II pilot, not randomized (25 patients received the intervention) | In 92% of the intervention group, taste-test scores improved by ≥2 points (p≤0.001). However, patients were included in the intervention group because they had low scores, so this result is completely vulnerable to "regression to the mean". Promising but uncontrolled. |
| Miracle fruit (miraculin) | Pilot randomized, triple-blind, placebo-controlled; 31 randomized, 21 completed | At the standard dose, improvement in electrical taste threshold and superiority to placebo in salty taste perception (p<0.05), with a difference in lean body mass (p=0.007). However, no patient reached a normal threshold, and the number completing the study is very small when divided between three arms. In head-and-neck radiotherapy, a phase 3 trial is registered—worth following. |
| Lactoferrin | Pilot, no control group, 26 patients | Significant improvement in taste score on day 60 (p=0.001)—but without a control arm it cannot be distinguished from natural recovery. The taste result on day 30 was already nonsignificant. |
| Plastic cutlery, lemon sweets, mouth rinses | No randomized studies | Recommended in patient education materials from major cancer centers. Harmless, inexpensive and worth trying—but never tested. |
| Intraoral cooling (ice chips) | A randomized study was published in 2025 | ⚠ We could not access its results. This method is classically used for mucositis; since mucositis is a verified risk factor for taste change (OR 3.72), an indirect benefit seems plausible. |
| Photobiomodulation (low-dose laser) | Established for mucositis, not for taste | MASCC/ISOO's 2025 review states that there is insufficient evidence for preventing dry mouth. Claims concerning taste could not be verified. |
MASCC/ISOO (the international supportive care and oral oncology associations) has separate guidelines for dry mouth, oral complications of immunotherapy and oral complications of targeted drugs—but none for taste change.
The conclusions of their systematic reviews on the subject are clear: "From the available literature, there is no predictable way to prevent or treat dysgeusia." Another review five years later: "Based on this review, an effective approach to preventing or managing taste and smell alterations in adult oncology patients is not yet apparent."
For the reader, this means the suggestions below are safe comfort measures that often provide relief; they are not proven treatments. Stating this clearly is better than promising an effect that does not exist. Note: because we could not access ESMO, ASCO, NCCN and ONS texts on taste change, no views have been attributed to these organizations.
Turkey: the figure that is this article's reason for existing
All the accessible taste-impairment data from Turkey are in oncology; we found no Turkish study of prevalence in the general population. In oncology, however, the data are both current and useful.
| Study | Patients | Finding |
|---|---|---|
| Taste change, malnutrition and quality of life in chemotherapy patients (2025) | 330 outpatient chemotherapy patients | Taste change 67.6% —almost exactly matching the international pooled estimate (70%). 21.8% were at moderate risk of malnutrition. |
| Taste alterations in lung cancer patients receiving chemotherapy (2022, Istanbul) | The chemotherapy unit of a teaching hospital | Taste change 62.3%. Most commonly described taste: metallic—35.8%. And this: 68.6% had received no information about this adverse effect. |
| Factors influencing taste change during cisplatin treatment (2025, Ankara) | 98 cisplatin patients | The model explains 76.4% of the variance in taste change. The strongest predictors are appetite loss (β=0.651) and quality of life (β=−0.464); the relationship between vomiting and discomfort with basic tastes is very strong (r=0.850). |
| Taste change in patients receiving chemotherapy (2019) | 112 patients | Scores were higher in women; taste-impairment scores were significantly higher in those with nausea, vomiting, constipation and mucositis. Mild malnutrition: 24.6%. |
Of Turkish lung cancer patients receiving chemotherapy, 68.6% said they had received no information about the taste change they experienced. An adverse effect occurring in over 60%, directly damaging patients' relationship with food and therefore their morale, had never been explained to two-thirds of patients—this is precisely the reason for this article and oncology nursing education. Moreover, this adverse effect does not require a proven treatment; it simply needs to be explained beforehand.
What can be done at home and during treatment?
Of the suggestions below, none has randomized-trial evidence for taste change. They all come from patient education materials at major cancer centers and clinical consensus. They are safe, inexpensive and help many patients—but they are not "proven treatments", and the two should not be confused.
- Step up oral care. Brush the teeth at least twice a day with a soft brush, and the tongue too, if your physician considers it appropriate. This suggestion has the most concrete evidence: taste perception has been shown to improve after gum treatment.
- Rinse your mouth before and after meals. A mild mouth-rinse recipe: 1 teaspoon of baking soda + 1 teaspoon of salt in 1 liter of warm water.
- Try plastic cutlery instead of metal. Never tested, but harmless, free and reported by many patients to help. Choosing food in glass, plastic or cardboard packaging instead of cans follows the same logic.
- Try sugar-free mints or chewing gum. Sugar-free is important: cancer patients with dry mouth are at high risk of tooth decay.
- Experiment with sour and spicy flavors and marinades. Marinating meat in sauces or citrus may mask the metallic taste. Important exception: if you have oral sores (mucositis), avoid sour and acidic foods —they hurt a sore mouth, and mucositis is already a risk factor for taste change.
- Increase fluid intake and take small sips throughout meals. Taste substances must dissolve in saliva to be perceived; dry mouth doubles the risk of taste change.
- Experiment with temperature and texture. Cold or room-temperature foods are often better tolerated; in the Turkish study, 35.8% of patients chose cold foods as a coping method.
- Avoid smoking and alcohol.
- Tell your team about taste impairment. Causes such as oral fungal infection, medication adverse effects and zinc deficiency that are treatable are only found when asked about.
Diagnosis: which physician, and for what?
For someone presenting with a metallic taste, the sequence is:
- Medication list. Every medication, supplement and herbal product started in the past three months. This is the most common cause and the easiest to address.
- Oral examination. Gum disease, thrush, nonhealing sores, denture problems, dry mouth. A dental assessment is often the missed step.
- Smell assessment. Remember the opening data: even among those with taste complaints alone, impairment is more often in smell. Skipping this step means looking in the wrong place.
- Blood tests. Depending on the situation: zinc, B12, a complete blood count, kidney and liver function, blood sugar.
- Referral to an ear, nose and throat specialist if necessary and imaging in selected cases. Taste tests, such as taste strips, are not available at every center in Turkey; when available, they turn a subjective complaint into an objective measurement.
For patients receiving cancer treatment, this sequence also includes assessment of mucositis and dry mouth and nutritional support. Although there is no proven treatment for taste change itself, managing these two accompanying, treatable problems makes a considerable difference to the patient's experience.
Frequently asked questions
- I constantly have a metallic taste in my mouth. Could it be a sign of serious disease?
- A metallic taste on its own is a weak indicator of serious disease. Medications are its most common cause. What determines seriousness is what accompanies the taste: assessment is needed if it starts within minutes with allergic symptoms, there is a new neurological sign, it occurs in recurrent attacks lasting seconds, there is an oral sore unhealed for three weeks, or it accompanies unexplained weight loss.
- I have lost my taste but my smell is intact—is that possible?
- Usually the opposite is true. Even among people complaining only of taste, smell is more often impaired (44.4% versus 25.4%). Also, most people saying "I can smell" mean sniffing through the nose, whereas food flavor comes from retronasal smell traveling from the mouth to the back of the nose, and the two can be impaired independently. Smell testing should therefore not be omitted from assessment.
- Is taste change during chemotherapy permanent?
- Usually not. In most patients, chemotherapy-related taste change improves within a few months of treatment ending. The situation differs in head-and-neck radiotherapy: most patients improve substantially within months, but a minority of approximately one-quarter to one-third have persistent impairment.
- Will zinc supplements improve it?
- It depends—and this distinction is very important. Randomized trials have found zinc effective in people with zinc deficiency, unexplained taste impairment and kidney-failure-related taste impairment. In contrast, for taste change caused by cancer treatment, the largest phase III trial was negative. Effective doses are also far above daily requirements, and prolonged high-dose zinc causes copper deficiency. It should not be started without checking blood levels and physician supervision.
- Does using plastic cutlery instead of metal really work?
- We do not know—it has never been tested. Major cancer centers recommend it in patient education materials, most patients say it helps, and it has no harm or cost. It is a comfort measure worth trying, not a proven treatment. This article's position is to distinguish the two.
- Would replacing my dental fillings make it go away?
- A metallic sensation for a few days after a new filling is real and usually temporary. However, recommending wholesale replacement of all metal dental work for chronic metallic taste is not an evidence-based approach. You encounter this recommendation more in promotional texts than clinical literature. Assess your medication list, gum health and dry mouth first.
Glossary
- Dysgeusia
- Alteration or distortion of taste. Also used as an umbrella term for taste disorders.
- Phantogeusia
- A taste perceived when nothing is in the mouth; a "phantom taste". The typical form of metallic taste.
- Hypogeusia / Ageusia
- Reduced and completely lost taste, respectively. True ageusia is very rare.
- Retronasal smell
- Smell perceived through the back of the nose from the mouth during chewing and swallowing. This accounts for much of what we call food's "taste".
- Xerostomia / hyposalivation
- The mouth feeling dry / a measured reduction in salivary flow. They are not the same thing.
- Chorda tympani
- The nerve that carries taste information from the front two-thirds of the tongue and passes through the middle ear. It is the anatomical explanation for taste impairment after ear and tonsil surgery.
- Mucositis
- Inflammation and sores inside the mouth caused by cancer treatment. It increases taste-change risk approximately fourfold.
- OR (odds ratio)
- A measure showing how many times a factor increases risk. If the confidence interval includes 1, the result is not statistically significant.
- Phase III trial
- A study type testing whether a treatment works, usually against placebo, in a large number of patients. One of the designs with the highest evidence value.
DROZDOGAN Academy Commentary
At first glance, this seems a small subject. Yet it is instructive in diagnostic reasoning and touches on one of the most neglected adverse effects in oncology practice. What struck us most while preparing the article was how much popular information in this field fell apart when its sources were checked.
⚡ Why does this subject matter?
Taste is central to our relationship with food and therefore daily life. When a person receiving cancer treatment says "nothing tastes of anything", this is more than a comfort issue: it is a loss affecting appetite, nutrition and morale simultaneously. Yet it barely appears on the lists of adverse effects discussed before treatment. The 68.6% figure from Turkey—two-thirds of patients having received no information about it—is a measure of this.
✅ Strengths / what is improving
The field has genuinely progressed in the past five years. Chemotherapy prevalence is now known through a pooled estimate. An elegant study using patients' relatives as a control group showed that immunotherapy does not cause persistent taste loss. In long COVID, taste buds were shown to remain intact, with the problem lying in signal transmission—a real source of hope for people fearing permanent damage. How targeted drugs disrupt taste bud renewal has been described. Work continues in radiotherapy to define taste-bud-bearing tongue mucosa as an organ to protect.
⚠️ Limitations / what should not be exaggerated
Much of the information circulating on this subject lacks sources. When we traced the "86% taste change" figure, we reached a different endpoint in a different patient group. "Listed in 17% of leaflets" is reported as "17% of medications cause taste impairment". Linking metallic taste to the liver is inconsistent with literature largely attributing it in liver patients to medications. The association with "heavy metal poisoning" proved much more weakly founded than expected. The treatment picture is clear: MASCC/ISOO has no separate taste guideline; zinc and glutamine trials in cancer patients are negative; apparently positive studies are either not randomized or very small.
🩺 Our practical position
- We explain it before treatment begins. Explaining in advance that taste may change, is likely to be temporary and can be managed is more effective than trying to treat it afterward—because we have no effective treatment in any case.
- When a complaint arises, we check the medication list first, not cancer treatment. A patient receiving chemotherapy may also be taking metformin.
- We examine the mouth. Thrush and gum disease are both common and easy to treat; neither will be found without asking.
- We treat mucositis and dry mouth separately. Although taste change itself has no proven treatment, treatments exist for these two problems that increase its risk two- to fourfold.
- We use zinc only after checking its level and with a physician's decision —also explaining that evidence of efficacy is lacking, particularly in cancer patients.
- We do not present comfort suggestions as "proven treatments". Plastic cutlery and lemon sweets can be tried; but telling a patient "this will cure it" undermines trust when it does not work.
- We do not omit smell assessment in persistent complaints that are not one-sided.
❓ Open questions
It remains unresolved whether the main determinant in radiotherapy is the dose to tongue mucosa or the salivary glands; this will directly determine where dose limits should be set. Miracle fruit (miraculin) has progressed from a pilot study to phase 3—its result may or may not provide this field's first real treatment. We have not yet accessed the results of the randomized study testing the effect of intraoral cooling on taste. And the most fundamental question: in long COVID, why does expression of signaling molecules decrease while taste buds remain intact, and is this reversible?
This article is limited to figures whose sources could be verified. Points deliberately omitted or corrected:
- Corrected: The statement "taste change in 86% of people receiving cancer treatment" was not used because it could not be verified (the closest traceable source concerned a different patient group and taste or smell impairment). The finding "17% of 1,645 medications" was corrected by specifying that it came from a leaflet-database review. The statement "a rusty taste in the mouth is associated with a liver problem" was corrected to say that liver disease reduces taste acuity and that the literature attributes metallic taste to medications. The figure "200 thousand visits a year in the United States" was not used as headline data because it is an old, unsourced institutional estimate. Hay fever was not presented as a verified cause of taste impairment.
- Figures not given because they could not be verified: drug-specific taste-impairment frequencies for captopril, clarithromycin, lithium, disulfiram, gold salts, iron supplements and others; taste-change rates for platinum, cyclophosphamide, methotrexate and 5-FU; frequency in dialysis patients; frequency in stroke, epilepsy and chorda tympani injury; frequency in oral fungal infection; a Gy threshold for radiotherapy, because the accessible source was internally inconsistent; a pooled rate for chronic rhinosinusitis.
- Sources whose contents could not be accessed: the randomized intraoral-cooling study published in 2025; the scoping review of chronic kidney disease and dysgeusia; a confidence interval from the zinc meta-analysis, not used because it appeared asymmetric around the point estimate as published; and ESMO, ASCO, NCCN and ONS texts on taste change—no views were therefore attributed to these organizations.
- Turkey: No Turkish study of taste-impairment prevalence in the general population was found. Information about the prescription status of zinc products is based on the regulation dated 20.12.2019; its currency in 2026 has not been verified. No information on SGK reimbursement rules has been provided, because current legislation could not be accessed—if this information is needed, it should be confirmed in the current SUT text.
- Internal links ("Related topics") are estimated addresses; they should be replaced with the actual addresses on the site before publication.
This article is for information and does not replace personalized medical advice. Do not stop or change your medication on your own; consult your physician before starting a supplement.
References
- Liu G, Zong G, Doty RL, Sun Q. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: a cross-sectional study. BMJ Open. 2016;6(11):e013246.
- Rawal S, Hoffman HJ, Bainbridge KE, et al. Prevalence and Risk Factors of Self-Reported Smell and Taste Alterations: Results from the 2011-2012 NHANES. Chem Senses. 2016;41(1):69-76.
- Claus LE, Leland EM, Tai KY, et al. Olfactory Loss and Beyond: A Practical Review of Chemosensory Dysfunction. J Am Board Fam Med. 2022;35(2):406-419.
- Rademacher WMH, Aziz Y, Hielema A, et al. Oral adverse effects of drugs: Taste disorders. Oral Dis. 2020;26(1):213-223.
- Fark T, Hummel C, Hähner A, Nin T, Hummel T. Characteristics of taste disorders. Eur Arch Otorhinolaryngol. 2013;270(6):1855-1860.
- Hannum ME, Koch RJ, Ramirez VA, et al. Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis. Chem Senses. 2023;48:bjad043.
- Tan BKJ, Han R, Zhao JJ, et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ. 2022;378:e069503.
- Mozaffar B, Ardavani A, Muzafar H, Idris I. The Effectiveness of Zinc Supplementation in Taste Disorder Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Nutr Metab. 2023;2023:6711071.
- Halyard MY, Jatoi A, Sloan JA, et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial. Int J Radiat Oncol Biol Phys. 2007;67(5).
- Zhang B, Zhang N, Zhang Y, et al. Prevalence and risk factors of chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis. Eur J Oncol Nurs. 2024;74:102735.
- Gunn L, Gilbert J, Nenclares P, et al. Taste dysfunction following radiotherapy to the head and neck: A systematic review. Radiother Oncol. 2021;157:130-140.
- Stieb S, et al. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients. Acta Oncol. 2022;61(2):146-152.
- Kaizu M, Komatsu H, Yamauchi H, et al. Characteristics of taste alterations in people receiving taxane-based chemotherapy and their association with appetite, weight, and quality of life. Support Care Cancer. 2021;29(9):5103-5114.
- Hovan AJ, Williams PM, Stevenson-Moore P, et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer. 2010;18(8):1081-1087.
- Thorne T, Olson K, Wismer W. A state-of-the-art review of the management and treatment of taste and smell alterations in adult oncology patients. Support Care Cancer. 2015;23(9):2843-2851.
- Strasser F, et al. Prevention of docetaxel- or paclitaxel-associated taste alterations in cancer patients with oral glutamine: a randomized, placebo-controlled, double-blind study. Oncologist. 2008;13(3):337-346.
- Pehlivan Köksal Z, Nural N. The effect of taste alteration on malnutrition and quality of life in patients undergoing chemotherapy. Support Care Cancer. 2025;33:431.
- Özkan İ, Eroğlu N. Kemoterapi Alan Akciğer Kanserli Hastalarda Tat Değişikliklerinin Değerlendirilmesi. Sürekli Tıp Eğitimi Dergisi (STED). 2022;31(1):33-42.
- Kurt B, Çakmak Öksüzoğlu BÖ. Factors Influencing Chemotherapy-Induced Taste Alterations in Cancer Patients Receiving Cisplatin Treatment: A Path Analysis. Cancer Control. 2025;32:1-9.
- Kędziora-Ciechańska A, Ciechański K, Chałas R. Impaired Gustation in Liver Diseases: A Comprehensive Narrative Literature Review. Acta Stomatol Croat. 2025;59(4):426-439.
- Ballin NZ. A Trial Investigating the Symptoms Related to Pine Nut Syndrome. J Med Toxicol. 2012;8(3):278-280.
- Tan HL, Renton T. Burning mouth syndrome: An update. Br J Pain. 2020.
- Nordin S, Broman DA, Olofsson JK, Wulff M. A Longitudinal Descriptive Study of Self-reported Abnormal Smell and Taste Perception in Pregnant Women. Chem Senses. 2004;29(5):391-402.
- Doty RL, Tourbier IA, Pham DL, et al. Taste dysfunction in multiple sclerosis. J Neurol. 2016;263(4):677-688.
- T.C. Sağlık Bakanlığı, Türkiye İlaç ve Tıbbi Cihaz Kurumu. Çinko İçeren Ürünler Hakkında. 20.12.2019.
Sources
Oral adverse effects of drugs: Taste disorders.
Oral Diseases, 18 September 2019.
2 .Taste Disorders.
https://www.nidcd.nih.gov/health/taste-disorders#5
Was this article helpful?
Your feedback helps us improve our content.
Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.